Identification of Serum MicroRNA-21 as a Biomarker for Chemosensitivity and Prognosis in Human Osteosarcoma

Objective: The aim of this study was to investigate the serum level of microRNA (miR)-21 in patients with osteosarcoma and its correlation with chemosensitivity and prognosis. Methods: miR-21 levels in sera from 65 patients with osteosarcoma and 30 healthy controls were measured by real-time reverse transcription-polymerase chain reaction. Correlations between serum miR-21 and clinicopathological features in patients with osteosarcoma were determined. The prognostic significance of serum miR-21 was assessed using a Cox proportional hazards model. Results: The serum level of miR-21 was significantly higher in patients with osteosarcoma than in control subjects. High serum miR-21 was significantly correlated with advanced Enneking stage and chemotherapeutic resistance. Univariate and multivariate analyses for overall survival showed that upregulation of serum miR-21 was an independent, unfavourable prognostic factor for patients with osteosarcoma (hazard ratio, 2.325). Conclusions: miR-21 might be a good candidate for a therapeutic target, and a potential biomarker for the prediction of chemotherapeutic sensitivity and prognosis in patients with osteosarcoma.

• Publication year

  2012

• Venue

  Journal of International Medical Research

• Publication date

  2012-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/030006051204000606PMID 23321165
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Circulating microRNAs in cancer: diagnostic and prognostic significance

  2012cited by this paper
• Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer.

  2011cited by this paper
• Serum miRNA‐21: Elevated levels in patients with metastatic hormone‐refractory prostate cancer and potential predictive factor for the efficacy of docetaxel‐based chemotherapy

  2011cited by this paper
• Serum MicroRNA-21 as Marker for Necroinflammation in Hepatitis C Patients with and without Hepatocellular Carcinoma

  2011cited by this paper
• PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis

  2011cited by this paper
• Long-Term Survivals of Stage IIB Osteosarcoma: A 20-Year Experience in a Single Institution

  2011cited by this paper
• Prognostic significance of serum miRNA‐21 expression in human non‐small cell lung cancer

  2011cited by this paper
• MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein.

  2010cited by this paper
• Genetic variation in microRNA networks: the implications for cancer research

  2010cited by this paper
• Circulating nucleic acids as a potential source for cancer biomarkers.

  2010cited by this paper
• Differential expression of microRNA (miRNA) in chordoma reveals a role for miRNA‐1 in Met expression

  2010cited by this paper
• microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells.

  2009cited by this paper
• Identification of interactive networks of gene expression associated with osteosarcoma oncogenesis by integrated molecular profiling.

  2009cited by this paper
• The epidemiology of osteosarcoma.

  2009cited by this paper
• MicroRNA reexpression as differentiation therapy in cancer.

  2009cited by this paper
• MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells.

  2009cited by this paper
• Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

  2008cited by this paper
• miR-21 microRNA expression in human gastric carcinomas and its clinical association.

  2008cited by this paper
• Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR.

  2008cited by this paper
• Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal Cancer

  2008cited by this paper
• Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma

  2008cited by this paper
• MicroRNA expression profiles of esophageal cancer.

  2008cited by this paper
• MicroRNA signatures in human ovarian cancer.

  2007cited by this paper
• MicroRNA expression profiles in head and neck cancer cell lines.

  2007cited by this paper
• MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.

  2007cited by this paper
• A microRNA expression signature of human solid tumors defines cancer gene targets

  2006cited by this paper
• Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines.

  2006cited by this paper
• MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior.

  2006cited by this paper
• Combinatorial microRNA target predictions

  2005cited by this paper
• MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.

  2005cited by this paper
• MicroRNA gene expression deregulation in human breast cancer.

  2005cited by this paper
• Ribo-gnome: The Big World of Small RNAs

  2005cited by this paper
• Biology and therapeutic advances for pediatric osteosarcoma.

  2004cited by this paper
• Osteosarcoma.

  1997cited by this paper
• A system of staging musculoskeletal neoplasms.

  1986cited by this paper
• Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy

  1982cited by this paper
• A System for the Surgical Staging of Musculoskeletal Sarcoma

  1980cited by this paper
• Minireview Mirnas Get an Early Start on Translational Silencing

  year unknowncited by this paper

• Non-Coding RNAs in Diagnostic Pathology of High-Grade Central Osteosarcoma

  2025cites this paper
• Biopsy Techniques for Musculoskeletal Tumors: Basic Principles and Specialized Techniques

  2024cites this paper
• Evaluating Circulating Biomarkers for Diagnosis, Prognosis, and Tumor Monitoring in Pediatric Sarcomas: Recent Advances and Future Directions

  2024cites this paper
• A comprehensive overview of liquid biopsy applications in pediatric solid tumors

  2024cites this paper
• Detection of circulating tumor-derived material in peripheral blood of pediatric sarcoma patients: A systematic review

  2023cites this paper
• Potential biomarkers for the early detection of bone metastases

  2023cites this paper
• Circulating and extracellular vesicle-derived microRNAs as biomarkers in bone-related diseases

  2023cites this paper
• A spotlight on the interplay of signaling pathways and the role of miRNAs in osteosarcoma pathogenesis and therapeutic resistance.

  2023cites this paper
• Oncogenic Dysregulation of Circulating Noncoding RNAs: Novel Challenges and Opportunities in Sarcoma Diagnosis and Treatment

  2022cites this paper
• Non-coding RNAs in drug and radiation resistance of bone and soft-tissue sarcoma: a systematic review

  2022cites this paper
• Non-coding RNAs as potential biomarkers in osteosarcoma

  2022cites this paper
• Liquid biopsies in primary and secondary bone cancers

  2022cites this paper
• Gene signatures with predictive and prognostic survival values in human osteosarcoma

  2021cites this paper
• MicroRNAs as prognostic biomarkers for survival outcome in osteosarcoma: A meta-analysis

  2021cites this paper
• The role of non‑coding RNAs in the regulation, diagnosis, prognosis and treatment of osteosarcoma (Review).

  2021cites this paper
• The role of microRNAs in the osteogenic and chondrogenic differentiation of mesenchymal stem cells and bone pathologies

  2021cites this paper
• Identification of osteosarcoma by microRNA‐coupled nuclease digestion on interdigitated electrode sensor

  2021cites this paper
• miR-21: a non‐specific biomarker of all maladies

  2021cites this paper
• Extracellular vesicle-associated repetitive element DNAs as candidate osteosarcoma biomarkers

  2021cites this paper
• MicroRNAs signatures, bioinformatics analysis of miRNAs, miRNA mimics and antagonists, and miRNA therapeutics in osteosarcoma

  2020cites this paper
• The new horizon of liquid biopsy in sarcoma: the potential utility of circulating tumor nucleic acids

  2020cites this paper
• Role of exosomal miR‑21 in the tumor microenvironment and osteosarcoma tumorigenesis and progression (Review).

  2020cites this paper
• Exosomes in sarcomas: Tiny messengers with broad implications in diagnosis, surveillance, prognosis and treatment.

  2019cites this paper
• Circulating miRNAs as Diagnostic and Prognostic Biomarkers in Common Solid Tumors: Focus on Lung, Breast, Prostate Cancers, and Osteosarcoma

  2019cites this paper
• LncRNA LINC-PINT Inhibits Cancer Cell Proliferation, Invasion, and Migration in Osteosarcoma by Downregulating miRNA-21

  2019cites this paper
• Noncoding RNAs as circulating biomarkers in osteosarcoma patients

  2019cites this paper
• miRNA signatures in childhood sarcomas and their clinical implications

  2019cites this paper
• Dissecting the functional role of microRNA 21 in osteosarcoma

  2019cites this paper
• Drug resistance‐related microRNAs in osteosarcoma: Translating basic evidence into therapeutic strategies

  2019cites this paper
• Correlations of MicroRNA‐21 Gene Polymorphisms With Chemosensitivity and Prognosis of Cervical Cancer

  2018cites this paper
• Application of liquid biopsy in bone and soft tissue sarcomas: Present and future.

  2018cites this paper
• miRNA-21 inhibition inhibits osteosarcoma cell proliferation by targeting PTEN and regulating the TGF-β1 signaling pathway

  2018cites this paper
• Blood‐borne biomarkers of osteosarcoma: A systematic review

  2018cites this paper
• MicroRNAs in Bone Diseases: Progress and Prospects

  2018cites this paper
• Emerging Role of microRNAs in Osteosarcoma-A Diagnostic , Prognostic , Therapeutic

  2018cites this paper
• Feasibility of IL21-immunotherapy for microRNA-21 associated osteosarcoma

  2018cites this paper
• Expression of plasma miR-106a in epithelial ovarian cancer and its diagnostic and prognostic significance

  2018cites this paper
• miR-133b induces chemoresistance of osteosarcoma cells to cisplatin treatment by promoting cell death, migration and invasion

  2017cites this paper
• miR-486 suppresses the development of osteosarcoma by regulating PKC-δ pathway

  2017cites this paper
• MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma

  2017cites this paper
• Noncoding RNA in drug resistant sarcoma

  2017influential citation
• Circulating microRNAs and Bioinformatics Tools to Discover Novel Diagnostic Biomarkers of Pediatric Diseases

  2017cites this paper
• The expression significance of serum MiR-21 in patients with osteosarcoma and its relationship with chemosensitivity.

  2017cites this paper
• Circulating microRNA-339-5p and -21 in plasma as an early detection predictors of lung adenocarcinoma.

  2017cites this paper
• Biomarker significance of plasma and tumor miR-21, miR-221, and miR-106a in osteosarcoma.

  2017cites this paper
• Biomarker significance of plasma and tumor miR-21, miR-221, and miR-106a in osteosarcoma

  2017cites this paper
• Potential therapeutic implications of miRNAs in osteosarcoma chemotherapy

  2017cites this paper
• Osteosarcoma Biomarkers Discovery Using “Omics” Approaches

  2017cites this paper
• The Biological Role and Clinical Implication of MicroRNAs in Osteosarcoma

  2017cites this paper
• Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma

  2017cites this paper
• MicroRNAs with prognostic significance in osteosarcoma: a systemic review and meta-analysis

  2017cites this paper
• Serum miR-300 as a diagnostic and prognostic biomarker in osteosarcoma

  2016cites this paper
• Role of microRNAs in primary central nervous system lymphomas

  2016cites this paper
• Circulating miR-21 as an independent predictive biomarker for chemoresistance in esophageal squamous cell carcinoma.

  2016cites this paper
• MicroRNAs in Bone and Soft Tissue Sarcomas and Their Value as Biomarkers

  2016cites this paper
• miRNAs Related to Skeletal Diseases

  2016cites this paper
• Involvement and Clinical Aspects of MicroRNA in Osteosarcoma

  2016cites this paper
• miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma

  2016cites this paper
• MicroRNA-21 Increases Proliferation and Cisplatin Sensitivity of Osteosarcoma-Derived Cells

  2016cites this paper
• Molecular mechanisms and microRNAs in osteosarcoma pathogenesis

  2016cites this paper
• Circulating microRNA-451 as a predictor of resistance to neoadjuvant chemotherapy in breast cancer

  2016cites this paper
• Identification of a Plasma Four-microRNA Panel as Potential Noninvasive Biomarker for Osteosarcoma

  2015cites this paper
• Biomarkers for Bone Tumors: Discovery from Genomics and Proteomics Studies and Their Challenges

  2015cites this paper
• Down-regulation of microRNA152 is associated with the diagnosis and prognosis of patients with osteosarcoma.

  2015cites this paper
• Critical role of miRNAs in pancreatic cancer.

  2015cites this paper
• MicroRNA-210 is upregulated by hypoxia-inducible factor-1α in the stromal cells of giant cell tumors of bone.

  2015cites this paper
• mir-21 Overexpressing Mesenchymal Stem Cells Accelerate Fracture Healing in a Rat Closed Femur Fracture Model

  2015cites this paper
• MicroRNAs in osteosarcoma.

  2015cites this paper
• Diagnostic value of circulating miR-21 for colorectal cancer: A meta-analysis

  2015cites this paper
• microRNA and Bone Cancer.

  2015cites this paper
• Circulating MicroRNAs in Sarcoma: Potential Biomarkers for Diagnosisand Targets for Therapy

  2014cites this paper
• Tumor-Suppressing Effects of miR-429 on Human Osteosarcoma

  2014cites this paper
• Prognostic role of circulating microRNA-21 in cancers: evidence from a meta-analysis

  2014cites this paper
• Serum levels of microRNA-133b and microRNA-206 expression predict prognosis in patients with osteosarcoma.

  2014cites this paper
• Clinical significance of microRNA-183/Ezrin axis in judging the prognosis of patients with osteosarcoma

  2014cites this paper
• Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.

  2014cites this paper
• MicroRNAs in osteosarcomagenesis.

  2014cites this paper
• Plasma miRNA levels correlate with sensitivity to bone mineral density in postmenopausal osteoporosis patients

  2014cites this paper
• Limb versus life—the outcomes of osteosarcoma in Cambodia

  2014cites this paper
• Tumor-Suppressing Effects of miR451 in Human Osteosarcoma

  2013cites this paper